Quantum Leap Healthcare Collaborative™ is a 501C(3) charitable organization integrating high-impact clinical research with patient care to improve and save lives.

PORTFOLIO

Learn more about our projects

I-SPY Trials

Developing new cancer treatments faster and for less

BreastCancerTrials.org

Personalized matching to breast cancer clinical trials

CTMatch

Customizing trial matching to other diseases

OneSource

Radically streamling collection and distribution of data

I-SPY COVID

Focusing on the Problem with an Important New Solution

Visit the I-SPY website for more information.

Latest News

August 27, 2020

Oncologists Train ARDS Docs for 'Inspirational' COVID-19 Trial

July 30, 2020

The COVID R&D Alliance and Quantum Leap Healthcare Enroll First Patients in I-SPY COVID Trials

July 7, 2020

Byondis’ Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2 TRIAL™

July 30, 2020

The COVID R&D Alliance and Quantum Leap Healthcare Enroll First Patients in I-SPY COVID Trials

August 7, 2019

KEYTRUDA’s Success in TNBC Validates I-SPY 2 Adaptive Approach to Phase II Trials

February 15, 2019

Esserman among bioscience leaders profiled in SF Business Times